DAC vs. OLMA

Last updated Jun 3, 2026

DAC (Danaos Corporation) and OLMA (Olema Pharmaceuticals, Inc.) are both stocks. DAC operates in Marine Shipping (Industrials), while OLMA operates in Biotechnology (Healthcare). Over the past 5 years, DAC returned 20.14%/yr vs -17.30%/yr for OLMA. At a 0.14 correlation, their price movements are largely independent.

Performance

DAC vs. OLMA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Danaos Corporation (DAC) and Olema Pharmaceuticals, Inc. (OLMA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DAC achieves a 38.84% return, which is significantly higher than OLMA's -57.24% return.

DAC

• 1D: 0.17%
• 1M: 8.28%
• YTD: 38.84%
• 6M: 35.39%
• 1Y: 55.90%
• 3Y*: 33.31%
• 5Y*: 20.14%
• 10Y*: 12.43%

OLMA

• 1D: -15.89%
• 1M: -25.35%
• YTD: -57.24%
• 6M: -60.63%
• 1Y: 144.34%
• 3Y*: 23.54%
• 5Y*: -17.30%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DAC vs. OLMA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
DAC Danaos Corporation	38.84%	22.24%	12.41%	47.51%	-26.57%	256.10%	45.19%
OLMA Olema Pharmaceuticals, Inc.	-57.24%	328.82%	-58.45%	472.65%	-73.82%	-80.53%	-1.88%

Correlation

The correlation between DAC and OLMA is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.14
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.15
Correlation (All Time) Calculated using the full available price history since Nov 20, 2020	0.14

Fundamentals

Market Cap DAC : $2.35B OLMA : $1.10B
EPS DAC : $28.34 OLMA : -$2.03
PB Ratio DAC : 0.60 OLMA : 2.29
Total Revenue (TTM) DAC : $1.04B OLMA : $0.00
Gross Profit (TTM) DAC : $705.76M OLMA : -$187.00K
EBITDA (TTM) DAC : $739.01M OLMA : -$197.79M

Return for Risk

DAC vs. OLMA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DAC

DAC Risk / Return Rank: 91
DAC Sharpe Ratio Rank: 92
DAC Sortino Ratio Rank: 92
DAC Omega Ratio Rank: 88
DAC Calmar Ratio Rank: 89
DAC Martin Ratio Rank: 92

OLMA

OLMA Risk / Return Rank: 76
OLMA Sharpe Ratio Rank: 68
OLMA Sortino Ratio Rank: 90
OLMA Omega Ratio Rank: 88
OLMA Calmar Ratio Rank: 68
OLMA Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DAC vs. OLMA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Danaos Corporation (DAC) and Olema Pharmaceuticals, Inc. (OLMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	DAC	OLMA	Difference
Sharpe ratio Return per unit of total volatility	2.62	0.90	+1.72
Sortino ratio Return per unit of downside risk	3.56	3.26	+0.30
Omega ratio Gain probability vs. loss probability	1.42	1.41	+0.01
Calmar ratio Return relative to maximum drawdown	4.46	1.46	+3.00
Martin ratio Return relative to average drawdown	14.34	3.12	+11.22
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

DAC vs. OLMA - Sharpe Ratio Comparison

The current DAC Sharpe Ratio is 2.62, which is higher than the OLMA Sharpe Ratio of 0.90. The chart below compares the historical Sharpe Ratios of DAC and OLMA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	DAC	OLMA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.62	0.90	+1.72
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.58	-0.16	+0.75
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.19	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.03	-0.23	+0.19

Drawdowns

DAC vs. OLMA - Drawdown Comparison

The maximum DAC drawdown since its inception was -99.42%, roughly equal to the maximum OLMA drawdown of -96.26%. Use the drawdown chart below to compare losses from any high point for DAC and OLMA.

Drawdown Indicators

	DAC	OLMA	Difference
Max Drawdown Largest peak-to-trough decline	-99.42%	-96.26%	-3.16%
Max Drawdown (1Y) Largest decline over 1 year	-12.58%	-70.16%	+57.58%
Max Drawdown (3Y) Largest decline over 3 years	-28.87%	-82.15%	+53.28%
Max Drawdown (5Y) Largest decline over 5 years	-50.14%	-93.36%	+43.22%
Max Drawdown (10Y) Largest decline over 10 years	-95.81%	—	—
Current Drawdown Current decline from peak	-67.00%	-80.39%	+13.39%
Average Drawdown Average peak-to-trough decline	-80.47%	-74.98%	-5.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.91%	32.85%	-28.94%

Volatility

DAC vs. OLMA - Volatility Comparison

The current volatility for Danaos Corporation (DAC) is 7.72%, while Olema Pharmaceuticals, Inc. (OLMA) has a volatility of 21.98%. This indicates that DAC experiences smaller price fluctuations and is considered to be less risky than OLMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DAC	OLMA	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.72%	21.98%	-14.26%
Volatility (6M) Calculated over the trailing 6-month period	16.63%	55.92%	-39.29%
Volatility (1Y) Calculated over the trailing 1-year period	21.44%	161.50%	-140.06%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.69%	107.97%	-73.28%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	65.07%	106.45%	-41.38%

Dividends

DAC vs. OLMA - Dividend Comparison

DAC's dividend yield for the trailing twelve months is around 2.76%, while OLMA has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
DAC Danaos Corporation	2.76%	3.66%	4.06%	4.12%	5.70%	2.01%
OLMA Olema Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both DAC and OLMA in my portfolio?

DAC and OLMA have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DAC or OLMA?

OLMA has higher volatility (21.98%) compared to DAC (7.72%). In terms of maximum drawdown, DAC dropped -99.42% vs OLMA's -96.26%.

Which has better risk-adjusted returns?

DAC currently has the higher Sharpe Ratio (2.62 vs 0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.